Vasoactive intestinal polypeptide (VIP) corrects chronic inflammatory response syndrome (CIRS) acquired following exposure to water-damaged buildings

@article{Shoemaker2013VasoactiveIP,
  title={Vasoactive intestinal polypeptide (VIP) corrects chronic inflammatory response syndrome (CIRS) acquired following exposure to water-damaged buildings},
  author={R. Shoemaker and D. House and J. C. Ryan},
  journal={Health},
  year={2013},
  volume={05},
  pages={396-401}
}
Exposure in water-damaged buildings (WDB) to airborne bioaerosols including metabolic products of toxigenic fungi, bacteria and actinomycetes; and inflammagens, can lead to a persistent innate immune inflammatory illness. [...] Key Method Here we report an open label trial of 20 patients with refractory CIRS-WDB illness who took replacement VIP in a nasal spray for at least 18 months with confirmation of durable efficacy and absence of significant side effects.Expand
14 Citations
Intranasal VIP safely restores volume to multiple grey matter nuclei in patients with CIRS
  • 1
...
1
2
...

References

SHOWING 1-10 OF 18 REFERENCES
Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis.
  • 115
Role of vasoactive intestinal peptide in inflammation and autoimmunity.
  • 40
  • Highly Influential
Vasoactive Intestinal Peptide Regulates Th17 Function in Autoimmune Inflammation
  • 42
  • Highly Influential
Anti‐inflammatory properties of the type 1 and type 2 vasoactive intestinal peptide receptors: role in lethal endotoxic shock
  • 86
  • Highly Influential
Vasoactive intestinal peptide induces vascular endothelial growth factor production in human HaCaT keratinocytes via MAPK pathway
  • 17
  • Highly Influential
Regulation of Dendritic Cell Differentiation by Vasoactive Intestinal Peptide
  • 32
  • Highly Influential
...
1
2
...